Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07176156

Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813

Suicide remains a serious public health issue in Flanders. Every day, nearly three people die by suicide, and many more attempt it or struggle with suicidal thoughts. The Zelfmoordlijn 1813 is a free and confidential helpline that offers support to people in crisis through phone, chat, and email. In 2024, volunteers had over 23,000 conversations, including nearly 3,000 via chat.

This study, led by the Flemish Centre of Expertise in Suicide Prevention (VLESP) in collaboration with the Centre for Suicide Prevention (CPZ), aims to better understand how people experience the chat service of the Zelfmoordlijn 1813. While previous research has looked at the impact of phone conversations, little is known about how chat conversations affect suicidal thoughts and feelings.

To explore this, people who contact the chat service will be invited to fill out a short questionnaire before and after their conversation. These questionnaires take about 3 minutes each and are completely voluntary. They ask about feelings like hopelessness, crisis, and perceived support, as well as satisfaction with the chat.

The goal is to improve the quality of chat-based crisis support and ensure that people in emotional distress receive the best possible help. This research will help strengthen suicide prevention efforts in Flanders.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Flemish Centre of Expertise in Suicide Prevention, Ghent University

Ghent, East-Flanders, 9000, Belgium

Location contact

Eva De Jaegere, PhD

CONTACT

[email protected]

+3293320775

Gwendolyn Portzky, PhD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • being at least 16 years of age
  • they are chatting on their own behalf (not for someone else)

Exclusion criteria

  • indication that they do not meet these criteria or are not interested in the study

Treatment and study plan

No intervention

Other

Observational one-time questionnaire study without intervention

Primary outcomes

  1. Changes in Suicidality

    Time frame: Pre- and post-measurement (immediately before and after the chat conversation)

    Suicidality is assessed using six key indicators: crisis, hopelessness, helplessness, sense of control, intent to die, and perceived social support. These indicators are measured through short online questionnaires administered before and after the chat conversation with the Suicide Line 1813.

    This set of indicators was selected based on prior research into the effectiveness of suicide prevention helplines and core concepts regarding suicidality.

Secondary outcomes

  1. User Satisfaction with the chat conversation.

    Time frame: Post-measurement (immediately after the chat conversation)

    During the post-measurement (immediately after the chat conversation), participants are asked about their satisfaction with the chat, their experiences regarding understanding and any additional comments they wish to share.

Other outcomes

  1. Socio-demographic data

    Time frame: pre-measurement (immediately before the chat conversation)

    Participants will be asked to provide the following demographic information: gender identity and age

Study contacts

Contact information is provided by the study sponsor or research team.

Eva De Jaegere, PhD

CONTACT

[email protected]

+3293320775

Sponsors and collaborators

Lead sponsor

University Ghent

Other

Registry information

Acronym: CHATQ-1813

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 16, 2025
Registry last updated
Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.